Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Shares Gap Down - Here's What Happened

Shares of Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $8.57, but opened at $8.27. Shionogi & Co., Ltd. Unsponsored ADR shares last traded at $8.27, with a volume of 954 shares traded.

Shionogi & Co., Ltd. Unsponsored ADR Stock Up 1.9%

The company has a debt-to-equity ratio of 0.01, a current ratio of 6.63 and a quick ratio of 6.13. The stock has a market capitalization of $14.70 billion, a PE ratio of 14.45, a PEG ratio of 1.95 and a beta of 0.18. The company has a 50 day moving average price of $8.24 and a 200-day moving average price of $7.63.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) last released its quarterly earnings results on Monday, May 12th. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.03). The company had revenue of $721.77 million for the quarter, compared to analyst estimates of $824.23 million. As a group, analysts forecast that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 earnings per share for the current fiscal year.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.